Anne Carol Goldberg, MD, an associate professor of medicine in the division of endocrinology, metabolism and lipid research at Washington University School of Medicine in St. Louis. A former president of the National Lipid Association, she has participated in numerous clinical trials involving the use of lipid-modifying agents, including the Lipid Research Clinic Coronary Primary Prevention Trial, which was one of the first to show that lowering blood cholesterol levels decreases risk for coronary artery disease.
State-of-the art treatment can reduce LDL by up to 75% Most of the estimated 42 million Americans with high cholesterol…
